Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; the old revision badge was removed and the new one added.SummaryDifference0.0%

- Check13 days agoChange DetectedRemoved the related topics 'Multiple myeloma' and 'MedlinePlus Genetics' from the study page.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded the disease term 'Multiple myeloma' as a key context on the study page and linked 'MedlinePlus Genetics' as a related topic. These additions enhance context and navigation for readers seeking disease-specific information.SummaryDifference0.1%

- Check27 days agoChange DetectedDeleted the study disease name 'Multiple myeloma' and removed the 'MedlinePlus related topics' section, including the 'MedlinePlus Genetics' link. This reduces visibility of the principal condition and related resources.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.4.2 has been added, and the previous notices about government funding lapse and the Revision: v3.4.1 have been removed.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a site-wide Notice about a lapse in government funding and that the NIH Clinical Center is open, with references to cc.nih.gov and opm.gov. Updated the platform revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.